EVALUATION OF THE POTENTIAL FOR STEADY-STATE PHARMACOKINETIC INTERACTION BETWEEN ATORVASTATIN AND ASPIRIN IN HEALTHY SUBJECTS.

被引：0
|
作者：
Cho, H. [1 ]
Cho, D. [1 ]
Yeo, C. [1 ]
Bae, S. [1 ]
Shon, J. [1 ]
Park, S. [1 ]
Kim, E. [1 ]
Shin, J. [1 ]
机构：
[1] Inje Univ, Busan Paik Hosp, Pusan, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [1] Lack of pharmacokinetic interaction between retigabine and phenobarbital at steady-state in healthy subjects.
    Ferron, GM
    Patat, A
    Parks, V
    Rolan, P
    Troy, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P48 - P48
  • [2] Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjects
    Ayalasomayajula, Surya P.
    Dole, Kiran
    He, Yan-Ling
    Ligueros-Saylan, Monica
    Wang, Yibin
    Campestrini, Joelle
    Humbert, Henri
    Sunkara, Gangadhar
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (12) : 2913 - 2920
  • [3] Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy subjects.
    Liu, P
    Foster, G
    Labadie, R
    Gutierrez, MJ
    Sharma, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P40 - P40
  • [4] PHARMACOKINETIC INTERACTION BETWEEN ATORVASTATIN AND MEITORMIN AT STEADY-STATE IN HEALTHY KOREAN VOLUNTEERS.
    Choi, H.
    Kim, D.
    Seo, J.
    Ghim, J.
    Koo, Y.
    Shin, J.
    Kim, E.
    Kim, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S40 - S40
  • [5] Lack of pharmacokinetic interaction between retigabine and phenobarbitone at steady-state in healthy subjects
    Ferron, GM
    Patat, A
    Parks, V
    Rolan, P
    Troy, SM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (01) : 39 - 45
  • [6] Steady-state PK of omapatrilat in healthy subjects.
    Delaney, CL
    Jemal, M
    Beierle, FA
    Ferreira, IM
    Davis, KD
    Meier, A
    Ford, NF
    Uderman, HD
    Liao, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 133 - 133
  • [7] Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects.
    Sunkara, G
    Reynolds, CV
    Pommier, F
    Humbert, H
    Yeh, CM
    McLeod, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1067 - 1067
  • [8] No pharmacokinetic interaction between nebivolol and furosemide in healthy subjects.
    Morton, TL
    Liu, S
    Phillips, JL
    Donnelly, CM
    Rackley, RJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P79 - P79
  • [9] No pharmacokinetic interaction between saxagliptin and digoxin in healthy subjects.
    Boulton, D. W.
    Li, L.
    Patel, C. G.
    Komoroski, B. J.
    Whigan, D.
    Frevert, E. U.
    Kornhauser, D. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S93 - S93
  • [10] Pharmacokinetic-Pharmacodynamic Investigation of a Possible Interaction Between Steady-State Temocapril and Warfarin in Healthy Subjects
    Gert Lankhaar
    Peter Eckenberger
    Mathieu J. A. Ouwerkerk
    Jasper Dingemanse
    Clinical Drug Investigation, 1999, 17 : 399 - 405
12345